CELU Valuation

Celularity Inc

Add to Watchlist

Advanced Chart

3.160

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

CELU Relative Valuation

CELU's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CELU is overvalued; if below, it's undervalued.

Historical Valuation

Celularity Inc (CELU) is now in the Undervalued zone, suggesting that its current forward PS ratio of 1.15 is considered Undervalued compared with the five-year average of -3.38. The fair price of Celularity Inc (CELU) is between 5.13 to 9.49 according to relative valuation methord. Compared to the current price of 3.28 USD , Celularity Inc is Undervalued By 36.06%.

Relative Value

Fair Zone

5.13-9.49

Current Price：3.28

36.06%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

9.16

P/B

Median3y

1.93

Median5y

1.51

-7.33

FCF Yield

Median3y

-72.89

Median5y

-57.81

Competitors Valuation Multiple

The average P/S ratio for CELU's competitors is 3.53, providing a benchmark for relative valuation. Celularity Inc Corp (CELU) exhibits a P/S ratio of 1.37, which is -61.24% above the industry average. Given its robust revenue growth of 49.70%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap